Intravitreal bevacizumab for treatment of central serous chorioretinopathy

Intravitreal bevacizumab for treatment of central serous chorioretinopathy

Purpose: To compare the outcomes of treatment with intravitreal bevacizumab (IVB) versus observation in central serous chorioretinopathy (CSCR). Methods: In a retrospective comparative study, records of 45 patients with CSCR were reviewed. Twenty-two patients received IVB (1.25 mg/0.05 ml) while 23...

Full description

Bibliographic Details
Main Authors: Cihan Ünlü, Gurkan Erdogan, Tugba Aydogan, Betul Ilkay Sezgin Akcay, Esra Kardes, Gulunay Akcali Kiray, Tahir Kansu Bozkurt
Format: Article
Language:English
Published: Knowledge E 2016-01-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Intravitreal Bevacizumab (Avastin); Central Serous Chorioretinopathy; Macular Thickness; Observation
Online Access:http://www.jovr.org/article.asp?issn=2008-322X;year=2016;volume=11;issue=1;spage=61;epage=65;aulast=Ünlü

Internet

http://www.jovr.org/article.asp?issn=2008-322X;year=2016;volume=11;issue=1;spage=61;epage=65;aulast=Ünlü

Similar Items